Back

STADE-HF: A Titration based on sST2 is safe but failed to decrease readmissions in patients admitted for acute heart failure.

25 May 2019 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30 Treatment HFA Premium Access Heart Failure 2019

About the speaker

Photo
Mr Jean Nicoleau

Montpellier (France)

14 More presentations in this session

Presentation thumbnail
Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre
Miss S. Lyu (Beijing, CN)
Slides
Presentation thumbnail
Interplay of stress regulatory transcription factors in human cardiac valvular disorders leading to heart failure and cross talk of NFAtc3 nuclear localization invitro.
Professor I. Murtaza (Islamabad, PK)
Slides
Presentation thumbnail
Who is taking care of decompensations of patients after a de novo AHF episode? An outlook on the natural history through the NOVICA cohort
Doctor O. Miro (Barcelona, ES)
Presentation thumbnail
Analysis on how the emergency physician decision of hospitalization or discharge home patients with acute heart failure matches with the risk categories stratified by the MEESSI scale
Doctor O. Miro (Barcelona, ES)
Presentation thumbnail
Beneficial effects of AT-001, an aldose reductase inhibitor, in rodent models of diabetic cardiomyopathy
Doctor R. Perfetti (New York, US)

Access the full session

Session thumbnail
Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

The Event

Event poster

Heart Failure 2019

25 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources